Cargando…

Current hotspot and study trend of innate immunity in COVID-19: a bibliometric analysis from 2020 to 2022

BACKGROUND: Since the coronavirus disease 2019 (COVID-19) has spread throughout the world, many studies on innate immunity in COVID-19 have been published, and great progress has been achieved, while bibliometric analysis on hotspots and research trends in this field remains lacking. METHODS: On 17...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Ping, Xu, Shuquan, Xue, Jin-hua, Zhang, Hong-zhou, Zhong, Yi-ming, Liao, Yong-ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206249/
https://www.ncbi.nlm.nih.gov/pubmed/37234160
http://dx.doi.org/10.3389/fimmu.2023.1135334
_version_ 1785046187480449024
author Lai, Ping
Xu, Shuquan
Xue, Jin-hua
Zhang, Hong-zhou
Zhong, Yi-ming
Liao, Yong-ling
author_facet Lai, Ping
Xu, Shuquan
Xue, Jin-hua
Zhang, Hong-zhou
Zhong, Yi-ming
Liao, Yong-ling
author_sort Lai, Ping
collection PubMed
description BACKGROUND: Since the coronavirus disease 2019 (COVID-19) has spread throughout the world, many studies on innate immunity in COVID-19 have been published, and great progress has been achieved, while bibliometric analysis on hotspots and research trends in this field remains lacking. METHODS: On 17 November 2022, articles and reviews on innate immunity in COVID-19 were recruited from the Web of Science Core Collection (WoSCC) database after papers irrelevant to COVID-19 were further excluded. The number of annual publications and the average citations per paper were analyzed by Microsoft Excel. Bibliometric analysis and visualization of the most prolific contributors and hotspots in the field were performed by VOSviewer and CiteSpace software. RESULTS: There were 1,280 publications that met the search strategy on innate immunity in COVID-19 and were published from 1 January 2020 to 31 October 2022. Nine hundred thirteen articles and reviews were included in the final analysis. The USA had the highest number of publications (Np) at 276 and number of citations without self-citations (Nc) at 7,085, as well as an H-index of 42, which contributed 30.23% of the total publications, followed by China (Np: 135, Nc: 4,798, and H-index: 23) with 14.79% contribution. Regarding Np for authors, Netea, Mihai G. (Np: 7) from the Netherlands was the most productive author, followed by Joosten, Leo A. B. (Np: 6) and Lu, Kuo-Cheng (Np: 6). The Udice French Research Universities had the most publications (Np: 31, Nc: 2,071, H-index: 13), with an average citation number (ACN) at 67. The journal Frontiers in Immunology possessed the most publications (Np: 89, Nc: 1,097, ACN: 12.52). “Evasion” (strength 1.76, 2021-2022), “neutralizing antibody” (strength 1.76, 2021-2022), “messenger RNA” (strength 1.76, 2021-2022), “mitochondrial DNA” (strength 1.51, 2021-2022), “respiratory infection” (strength 1.51, 2021-2022), and “toll-like receptors” (strength 1.51, 2021-2022) were the emerging keywords in this field. CONCLUSION: The study on innate immunity in COVID-19 is a hot topic. The USA was the most productive and influential country in this field, followed by China. The journal with the most publications was Frontiers in Immunology. “Messenger RNA,” “mitochondrial DNA,” and “toll-like receptors” are the current hotspots and potential targets in future research.
format Online
Article
Text
id pubmed-10206249
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102062492023-05-25 Current hotspot and study trend of innate immunity in COVID-19: a bibliometric analysis from 2020 to 2022 Lai, Ping Xu, Shuquan Xue, Jin-hua Zhang, Hong-zhou Zhong, Yi-ming Liao, Yong-ling Front Immunol Immunology BACKGROUND: Since the coronavirus disease 2019 (COVID-19) has spread throughout the world, many studies on innate immunity in COVID-19 have been published, and great progress has been achieved, while bibliometric analysis on hotspots and research trends in this field remains lacking. METHODS: On 17 November 2022, articles and reviews on innate immunity in COVID-19 were recruited from the Web of Science Core Collection (WoSCC) database after papers irrelevant to COVID-19 were further excluded. The number of annual publications and the average citations per paper were analyzed by Microsoft Excel. Bibliometric analysis and visualization of the most prolific contributors and hotspots in the field were performed by VOSviewer and CiteSpace software. RESULTS: There were 1,280 publications that met the search strategy on innate immunity in COVID-19 and were published from 1 January 2020 to 31 October 2022. Nine hundred thirteen articles and reviews were included in the final analysis. The USA had the highest number of publications (Np) at 276 and number of citations without self-citations (Nc) at 7,085, as well as an H-index of 42, which contributed 30.23% of the total publications, followed by China (Np: 135, Nc: 4,798, and H-index: 23) with 14.79% contribution. Regarding Np for authors, Netea, Mihai G. (Np: 7) from the Netherlands was the most productive author, followed by Joosten, Leo A. B. (Np: 6) and Lu, Kuo-Cheng (Np: 6). The Udice French Research Universities had the most publications (Np: 31, Nc: 2,071, H-index: 13), with an average citation number (ACN) at 67. The journal Frontiers in Immunology possessed the most publications (Np: 89, Nc: 1,097, ACN: 12.52). “Evasion” (strength 1.76, 2021-2022), “neutralizing antibody” (strength 1.76, 2021-2022), “messenger RNA” (strength 1.76, 2021-2022), “mitochondrial DNA” (strength 1.51, 2021-2022), “respiratory infection” (strength 1.51, 2021-2022), and “toll-like receptors” (strength 1.51, 2021-2022) were the emerging keywords in this field. CONCLUSION: The study on innate immunity in COVID-19 is a hot topic. The USA was the most productive and influential country in this field, followed by China. The journal with the most publications was Frontiers in Immunology. “Messenger RNA,” “mitochondrial DNA,” and “toll-like receptors” are the current hotspots and potential targets in future research. Frontiers Media S.A. 2023-05-10 /pmc/articles/PMC10206249/ /pubmed/37234160 http://dx.doi.org/10.3389/fimmu.2023.1135334 Text en Copyright © 2023 Lai, Xu, Xue, Zhang, Zhong, Liao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Lai, Ping
Xu, Shuquan
Xue, Jin-hua
Zhang, Hong-zhou
Zhong, Yi-ming
Liao, Yong-ling
Current hotspot and study trend of innate immunity in COVID-19: a bibliometric analysis from 2020 to 2022
title Current hotspot and study trend of innate immunity in COVID-19: a bibliometric analysis from 2020 to 2022
title_full Current hotspot and study trend of innate immunity in COVID-19: a bibliometric analysis from 2020 to 2022
title_fullStr Current hotspot and study trend of innate immunity in COVID-19: a bibliometric analysis from 2020 to 2022
title_full_unstemmed Current hotspot and study trend of innate immunity in COVID-19: a bibliometric analysis from 2020 to 2022
title_short Current hotspot and study trend of innate immunity in COVID-19: a bibliometric analysis from 2020 to 2022
title_sort current hotspot and study trend of innate immunity in covid-19: a bibliometric analysis from 2020 to 2022
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206249/
https://www.ncbi.nlm.nih.gov/pubmed/37234160
http://dx.doi.org/10.3389/fimmu.2023.1135334
work_keys_str_mv AT laiping currenthotspotandstudytrendofinnateimmunityincovid19abibliometricanalysisfrom2020to2022
AT xushuquan currenthotspotandstudytrendofinnateimmunityincovid19abibliometricanalysisfrom2020to2022
AT xuejinhua currenthotspotandstudytrendofinnateimmunityincovid19abibliometricanalysisfrom2020to2022
AT zhanghongzhou currenthotspotandstudytrendofinnateimmunityincovid19abibliometricanalysisfrom2020to2022
AT zhongyiming currenthotspotandstudytrendofinnateimmunityincovid19abibliometricanalysisfrom2020to2022
AT liaoyongling currenthotspotandstudytrendofinnateimmunityincovid19abibliometricanalysisfrom2020to2022